Kiniksa Pharmaceuticals International (KNSA) Tax Provisions (2017 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Tax Provisions came in at $5.7 million in Q2 2026, up 13.24% YoY from $5.0 million in Q2 2025, and down 43.37% on a QoQ basis from $10.1 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Tax Provisions (2017 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 10 years of Tax Provisions data on file, last reported at $5.7 million in Q2 2026.
- Quarterly Tax Provisions rose 13.24% year-over-year to $5.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $33.6 million (up 254.67% YoY) and the FY2025 annual result came in at $29.9 million, up 324.13% from the prior year.
- Tax Provisions retreated to $5.7 million in Q2 2026, from $10.1 million in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $10.1 million in Q1 2026 to a low of -$177.4 million in Q3 2022.
- A 5-year average of -$8.4 million and a median of $4.2 million in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 816.67% in 2022, down 150203.39% in 2022.
- Tracing KNSA's Tax Provisions over 5 years: stood at $2.4 million in 2022, then plunged by 1057.44% to -$22.8 million in 2023, then jumped by 64.49% to -$8.1 million in 2024, then soared by 212.1% to $9.1 million in 2025, then sank by 37.01% to $5.7 million in 2026.
- The last three Tax Provisions figures came in at $5.7 million (Q2 2026), $10.1 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 121.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -310.32 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 39.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 54.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 17.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 2.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.13 Bn | 5.60 Bn | 220.03 Mn | 5.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.71 Mn |
| Mar 31, 2026 | 10.09 Mn |
| Dec 31, 2025 | 9.07 Mn |
| Sep 30, 2025 | 8.72 Mn |
| Jun 30, 2025 | 5.05 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | -8.09 Mn |
| Sep 30, 2024 | 5.49 Mn |
| Jun 30, 2024 | 6.21 Mn |
| Mar 31, 2024 | 3.43 Mn |
| Dec 31, 2023 | -22.79 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | -16.21 Mn |
| Mar 31, 2023 | 2.91 Mn |
| Dec 31, 2022 | 2.38 Mn |
| Sep 30, 2022 | -177.36 Mn |
| Jun 30, 2022 | 716,000.00 |
| Mar 31, 2022 | 1.93 Mn |
| Dec 31, 2021 | 279,000.00 |
| Sep 30, 2021 | -118,000.00 |